Company
EVIIVE
Empowering precision immunotherapy through blood-based diagnostics that decode immune signals and guide treatment with unmatched clarity, speed, and scalability.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Zürich, Switzerland
- Founded
- 2024
- Customers
- pharma
Claim, correct or request removal
Record updated 18 September 2026
About
EVIIVE is a Swiss biotech company pioneering the next generation of blood-based diagnostics through high-dimensional analysis of extracellular vesicles (EVs). Our mission is to unlock the immune system’s hidden signals to guide more precise, personalized treatment decisions — starting with immunotherapy in cancer.
Products
- Other
- IMPACT
- Other
- IMPASS
Loading relationship preview